首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II Study of 5-Fluorouracil,Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma
Authors:Thomas J. George  Azka Ali  Yu Wang  Ji-Hyun Lee  Alison M. Ivey  David DeRemer  Karen C. Daily  Carmen J. Allegra  Steven J. Hughes  Z. Hugh Fan  Miles E. Cameron  Andrew R. Judge  Jose G. Trevino
Affiliation:1. Division of Hematology Oncology, Department of Medicine, University of Florida, Gainesville, Florida, USA;2. Division of Quantitative  Sciences, University of Florida Health Cancer Center, Gainesville, Florida, USA;3. Department of Biostatistics, University of Florida, Gainesville, Florida, USA;4. University of Florida Health  Cancer Center, Gainesville, Florida, USA;5. Division of Hematology Oncology, Department of Medicine, University of Florida, Gainesville, Florida, USA

University of Florida Health  Cancer Center, Gainesville, Florida, USA;6. Department of Surgery, University of Florida, Gainesville, Florida, USA;7. Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, USA;8. College of Medicine, University of Florida, Gainesville, Florida, USA;9. Department of Physical Therapy, University of Florida, Gainesville, Florida, USA;10. Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA

Abstract:
Keywords:FOLFOX  Dasatinib  Metastatic pancreatic cancer  Src
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号